Batch Production Record (BPR) and Device History Record (DHR) Review and Quality Assessment
Jerry Dalfors
90 Min
Product Id: 703560
This webinar will provide the typical elements required to be included in the Batch Production Record and the Device History Record in order to accomplish a quality and cost effective review and quality assessment based on current regulatory expectations.
Introduction of Post-Marketing Drug Safety Surveillance: Pharmacovigilance in FDA / CDER
David Lilienfeld
90 Min
Product Id: 703479
This pharmacovigilance webinar will provide attendees an understanding of post-marketing drug safety surveillance, its role in lifecycle management, and the practices and regulations governing its conduct. It will describe the structure of the pharmacovigilance world including the ICH, the FDA, CIOMS, MHW, and EudraVigilance.
Current Trends in FDA Inspections
Michael Ferrante
90 Min
Product Id: 703485
This webinar will focus on the current trends in FDA inspections and guidelines that can be implemented to ensure compliance with the latest quality and regulatory requirements. Attendees will learn how to prepare for an FDA inspection to avoid Warning Letters.
Understanding CFR Part 210-211 Requirements for Drug Products
Jamie Jamshidi
90 Min
Product Id: 700931
This webinar will discuss in detail all parts of the regulations set forth in part 210 and in parts 211 of 21 CFR chapters. Attendees will learn how to comply with these regulations.
Supplier Qualification Audit, A Risk Based Approach
Yasamin Ameri
60 Min
Product Id: 703477
This webinar will discuss requirements for supplier and vendor qualifications. Attendees will learn how to develop a risk management plan for monitoring of suppliers, vendors and service providers. It will also discuss how to prevent recalls and advisory notices due to provided non-conforming materials or bad services.
Internal Auditing in Pharmaceutical Manufacturing - Lightning Rod & Steam Valve
Mitchell Ehrlich
60 Min
Product Id: 703465
This webinar will explain how to conduct an effective internal audit program. Attendees will learn the benefits of a well-designed and executed internal auditing program for GMP compliance enhancement, management informatics and for avoidance of whistleblower actions.
Responding to Unsolicited Requests for Off-Label Information
Mukesh Kumar
90 Min
Product Id: 703464
This webinar will discuss the FDA guidelines for handling unsolicited requests about off-label information. It will provide attendees a list of dos and don’ts related to social media techniques in off-label promotion.
Equipment Requalification: What and When it is Really Required?
Jennifer Medlar
60 Min
Product Id: 703450
This webinar will explain how to generate a practical and compliant methodology to handle equipment requalification. Attendees will learn about common pitfalls to avoid when requalifying equipment.
Regulatory Records Primer: Decoding the Requirements for Medical Device and Pharmaceutical Manufacturers
Les Schnoll
90 Min
Product Id: 703433
This webinar will explain FDA regulatory records requirements for medical devices and finished pharmaceuticals. It will cover statutory requirement, required content, format, purpose, retention, and structure for regulatory records for both medical devices and pharmaceuticals.
Quality Systems Approach for Validation and Maintenance of a Global ERP System
James Carron
90 Min
Product Id: 703424
This webinar will explain how to implement an Enterprise Resource Planning (ERP) system by integrating a company’s existing quality system. It will cover selection, analysis, initiation, design, validation and test phases, including change control.
The New European Union Clinical Trials Regulation: An Analysis of the Key Changes and their Implications for Future Clinical Trials
Ciara Farrell,Elisabethann Wright
60 Min
Product Id: 703445
This webinar will review the changes introduced by the new European Union ("EU") Clinical Trials Regulation and the implications for future clinical trials.
LDT including CDx; CLIA versus FDA's Authority
Abdel Halim
60 Min
Product Id: 703399
This webinar will explain the regulatory path of an in vitro diagnostic (IVD) and Laboratory Developed Test (LDT). It will discuss the CLIA regulations for Laboratory Developed Tests (LDTs), including companion diagnostics (CDx) and how these differ from the FDA’s authority.
CMC Considerations for INDs and NDAs for 505(b)(2) Products
Mukesh Kumar
90 Min
Product Id: 703393
This webinar will highlight the key elements of the Chemistry, Manufacturing and Controls (CMC) section of an IND and NDA application for a 505(b)(2) product using examples and case studies. It will also discuss role of Drug Master Files (DMFs), and cross reference authorizations.
Overview of Importing Foreign Cosmetic and OTC Products
Marc Sanchez
60 Min
Product Id: 703379
This webinar will cover key definitions like cosmetics, new drugs, adulteration and misbranding, including key concepts like color additive restrictions and labeling requirements. Attendees will learn best practices for responding to Warning Letters.
FDA Regulatory Actions: It's Not Just about Warning Letters
Fredric Richman
60 Min
Product Id: 703344
This training will outline the possible consequences for failing to promptly and adequately correct significant violations related to cGMPs, new drugs or devices, labeling or other regulatory issues resulting in advisory, administrative and judicial actions.
FDA Premarket Review of New and Modified Tobacco Products
Azim Chowdhury
60 Min
Product Id: 703127
This training on FDA regulatory requirements for tobacco products will focus on the premarket review of new and modified tobacco products. It will also discuss the impact of FDA deeming regulation for of e- cigarettes and novel tobacco products on premarket authorization requirements.
Supplier Quality Management: Implement it Now or Pay for it Later
Les Schnoll
90 Min
Product Id: 703357
This webinar will discuss FDA's requirements for medical device supplier management and the controls you need to have in place to ensure compliance with quality. It will cover how to structure a supplier quality agreement and the tools and methods you need for evaluating and assessing suppliers.
Are you prepared for a regulatory audit from FDA or any other regulatory body?
Philip Russ
90 Min
Product Id: 703355
This FDA audit training provides an overview of the audit readiness process from internal evaluation of your quality systems to the logistics of the audit itself; with key emphasis placed on equipping you and your team with the skills needed to present expert testimony during interviews with regulators.
Major Changes to the EU Clinical Trials Regulation: What is Required for Compliance
Laura Brown
60 Min
Product Id: 703336
This webinar will help Sponsors, CROs and study sites running clinical trials in the EU and internationally; understand the important, updated compliance requirements concerning the new EU Clinical Trials Regulation due to be enacted in 2016 and which will replace the 2001 Clinical Trials Directive (CTD) (2001/20/EC).
Regulatory Documentation for Clinical Trials
Adam Ruskin
60 Min
Product Id: 703329
This clinical research compliance training will explain in detail the list of required regulatory documentation for clinical trials for industries such as pharmaceutical, biotechnology, medical devices and diagnostics. It will also review many of the documents in terms of required content and structure.